Spondyloarthritis & psoriatic arthritis

Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study

Lancet RheumatolPublished Cross-sectional study

Authors' conclusion

Sacroiliac bone marrow oedema affects nearly one-third of adults, showing associations with pregnancy, overweight, and occupational physical stress rather than inflammatory disease.

Study context

Population
Adults aged 20–69 years from the German National Cohort who underwent whole-body MRI, May 2014–Dec 20165,432 [48.7%] women
Participants
11,163 adults
Exposure
Expert readers vs Deep-learning algorithm
  • Expert readersn = 998
  • Deep-learning algorithmn = 10,165
Outcome
Presence of sacroiliac bone marrow oedema
Methodological detailsnational, population-based, multivariable logistic regression, sex-stratified analyses
  • National
  • Population-based
  • Multivariable logistic regression
  • Sex-stratified analyses

Main finding

As reported in the abstract

Prevalence of sacroiliac bone marrow oedema
Self-reported axSpA diagnosis prevalence (BMO prevalence ≈50 times higher)
0.6%

Observational data: associations, not effects.

Further findings

OutcomeWomenMenEstimate
BMO prevalence by sex33.9% (95% CI 32.6–35.3)27.8% (95% CI 26.6–29.1)aOR 1.33 (95% CI 1.23–1.45)
BMO in women: pregnancy historyvs nulliparousOR 1.43 (95% CI 1.21–1.71)

BMO determinants by sex: age and recreational physical activity

Men: age, OR per decade
1.28 (95% CI 1.21-1.35)
Men: intensive recreational physical activity, OR (1.08-1.42)
1.24
Women: age, OR per decade (1.11-1.23)
1.16

BMO determinants overall: BMI ≥25 kg/m² and physically demanding occupational work

BMI 25 kg/m² and above, OR (1.47-1.79); highest OR of modifiable risk factors
1.62
Physically demanding occupational work, OR
1.25 (95% CI 1.14-1.36)

Original publication

Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study. Lancet Rheumatol. Published 6 May 2026. doi:10.1016/s2665-9913(26)00071-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.